Eli Lilly Unclassified
FDA Approved Drugs

Eli Lilly Unclassified

FDA Approved Drugs Database

FDA approved drug product records including application numbers, product numbers, drug names, active ingredients, dosage forms, strengths, approval dates and regulatory status.

Unclassified
  • Total Records 59
  • Latest Approval Date -
  • Data Source FDA
  • First Approval Date -
All
339
View
Unclassified
59
View
Discontinued
204
View
RX
76
View
Company Overview

Company

Eli Lilly Unclassified

Country

U.S.A

Website

Visit Website

Email

info@lilly.com

Social Profiles

LinkedIn X / Twitter
Company Snapshot

Eli Lilly Unclassified

Lilly Corporate Center, Indianapolis, Indiana 46285

U.S.A

www.lilly.com/ info@lilly.com View on Map
FDA Approved Drug Records ( 59 records )
-
Unclassified Application: 21677

Drug Name

ALIMTA

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

-

21677 / 1

Active Ingredient

PEMETREXED

Application Number

21677

Product Number

1

Dosage Form

-

Strength

500MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 205692

Drug Name

BASAGLAR

Product Number

1

Dosage Form

-

Strength

300 UNITS/3ML (100 UNITS/ML)

Approval Date

-

205692 / 1

Active Ingredient

INSULIN GLARGINE

Application Number

205692

Product Number

1

Dosage Form

-

Strength

300 UNITS/3ML (100 UNITS/ML)

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 21733

Drug Name

CYMBALTA

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

-

21733 / 1

Active Ingredient

DULOXETINE HYDROCHLORIDE

Application Number

21733

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 21733

Drug Name

CYMBALTA

Product Number

2

Dosage Form

-

Strength

EQ 30MG BASE

Approval Date

-

21733 / 2

Active Ingredient

DULOXETINE HYDROCHLORIDE

Application Number

21733

Product Number

2

Dosage Form

-

Strength

EQ 30MG BASE

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 21733

Drug Name

CYMBALTA

Product Number

4

Dosage Form

-

Strength

EQ 60MG BASE

Approval Date

-

21733 / 4

Active Ingredient

DULOXETINE HYDROCHLORIDE

Application Number

21733

Product Number

4

Dosage Form

-

Strength

EQ 60MG BASE

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 22148

Drug Name

CYMBALTA

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

-

22148 / 1

Active Ingredient

DULOXETINE HYDROCHLORIDE

Application Number

22148

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 22148

Drug Name

CYMBALTA

Product Number

2

Dosage Form

-

Strength

EQ 30MG BASE

Approval Date

-

22148 / 2

Active Ingredient

DULOXETINE HYDROCHLORIDE

Application Number

22148

Product Number

2

Dosage Form

-

Strength

EQ 30MG BASE

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 22148

Drug Name

CYMBALTA

Product Number

3

Dosage Form

-

Strength

EQ 60MG BASE

Approval Date

-

22148 / 3

Active Ingredient

DULOXETINE HYDROCHLORIDE

Application Number

22148

Product Number

3

Dosage Form

-

Strength

EQ 60MG BASE

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 22516

Drug Name

CYMBALTA

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

-

22516 / 1

Active Ingredient

DULOXETINE HYDROCHLORIDE

Application Number

22516

Product Number

1

Dosage Form

-

Strength

EQ 20MG BASE

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 22516

Drug Name

CYMBALTA

Product Number

2

Dosage Form

-

Strength

EQ 30MG BASE

Approval Date

-

22516 / 2

Active Ingredient

DULOXETINE HYDROCHLORIDE

Application Number

22516

Product Number

2

Dosage Form

-

Strength

EQ 30MG BASE

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 22516

Drug Name

CYMBALTA

Product Number

3

Dosage Form

-

Strength

EQ 60MG BASE

Approval Date

-

22516 / 3

Active Ingredient

DULOXETINE HYDROCHLORIDE

Application Number

22516

Product Number

3

Dosage Form

-

Strength

EQ 60MG BASE

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 125477

Drug Name

CYRAMZA

Product Number

1

Dosage Form

-

Strength

100MG/10ML

Approval Date

-

125477 / 1

Active Ingredient

RAMUCIRUMAB

Application Number

125477

Product Number

1

Dosage Form

-

Strength

100MG/10ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 125477

Drug Name

CYRAMZA

Product Number

2

Dosage Form

-

Strength

500MG/50ML

Approval Date

-

125477 / 2

Active Ingredient

RAMUCIRUMAB

Application Number

125477

Product Number

2

Dosage Form

-

Strength

500MG/50ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 761306

Drug Name

EBGLYSS

Product Number

1

Dosage Form

-

Strength

250MG/2ML

Approval Date

-

761306 / 1

Active Ingredient

LEBRIKIZUMAB-LBKZ

Application Number

761306

Product Number

1

Dosage Form

-

Strength

250MG/2ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 761063

Drug Name

EMGALITY

Product Number

1

Dosage Form

-

Strength

120MG/ML

Approval Date

-

761063 / 1

Active Ingredient

GALCANEZUMAB-GNLM

Application Number

761063

Product Number

1

Dosage Form

-

Strength

120MG/ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 22042

Drug Name

EVISTA

Product Number

1

Dosage Form

-

Strength

60MG

Approval Date

-

22042 / 1

Active Ingredient

RALOXIFENE HYDROCHLORIDE

Application Number

22042

Product Number

1

Dosage Form

-

Strength

60MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 20563

Drug Name

HUMALOG

Product Number

1

Dosage Form

-

Strength

100 UNITS/ML

Approval Date

-

20563 / 1

Active Ingredient

INSULIN LISPRO RECOMBINANT

Application Number

20563

Product Number

1

Dosage Form

-

Strength

100 UNITS/ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 20563

Drug Name

HUMALOG KWIKPEN

Product Number

3

Dosage Form

-

Strength

100 UNITS/ML

Approval Date

-

20563 / 3

Active Ingredient

INSULIN LISPRO RECOMBINANT

Application Number

20563

Product Number

3

Dosage Form

-

Strength

100 UNITS/ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 20563

Drug Name

HUMALOG KWIKPEN

Product Number

4

Dosage Form

-

Strength

200UNITS/ML

Approval Date

-

20563 / 4

Active Ingredient

INSULIN LISPRO RECOMBINANT

Application Number

20563

Product Number

4

Dosage Form

-

Strength

200UNITS/ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 205747

Drug Name

HUMALOG KWIKPEN

Product Number

1

Dosage Form

-

Strength

200 UNITS/ML

Approval Date

-

205747 / 1

Active Ingredient

INSULIN LISPRO RECOMBINANT

Application Number

205747

Product Number

1

Dosage Form

-

Strength

200 UNITS/ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 21018

Drug Name

HUMALOG MIX 50/50

Product Number

1

Dosage Form

-

Strength

50 UNITS/ML;50 UNITS/ML

Approval Date

-

21018 / 1

Active Ingredient

INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT

Application Number

21018

Product Number

1

Dosage Form

-

Strength

50 UNITS/ML;50 UNITS/ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 21018

Drug Name

HUMALOG MIX 50/50 KWIKPEN

Product Number

2

Dosage Form

-

Strength

50 UNITS/ML;50 UNITS/ML

Approval Date

-

21018 / 2

Active Ingredient

INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT

Application Number

21018

Product Number

2

Dosage Form

-

Strength

50 UNITS/ML;50 UNITS/ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 21018

Drug Name

HUMALOG MIX 50/50 PEN

Product Number

3

Dosage Form

-

Strength

50 UNITS/ML;50 UNITS/ML

Approval Date

-

21018 / 3

Active Ingredient

INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT

Application Number

21018

Product Number

3

Dosage Form

-

Strength

50 UNITS/ML;50 UNITS/ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 21017

Drug Name

HUMALOG MIX 75/25

Product Number

1

Dosage Form

-

Strength

75 UNITS/ML;25 UNITS/ML

Approval Date

-

21017 / 1

Active Ingredient

INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT

Application Number

21017

Product Number

1

Dosage Form

-

Strength

75 UNITS/ML;25 UNITS/ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 21017

Drug Name

HUMALOG MIX 75/25 KWIKPEN

Product Number

2

Dosage Form

-

Strength

75 UNITS/ML;25 UNITS/ML

Approval Date

-

21017 / 2

Active Ingredient

INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT

Application Number

21017

Product Number

2

Dosage Form

-

Strength

75 UNITS/ML;25 UNITS/ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 21017

Drug Name

HUMALOG MIX 75/25 PEN

Product Number

3

Dosage Form

-

Strength

75 UNITS/ML;25 UNITS/ML

Approval Date

-

21017 / 3

Active Ingredient

INSULIN LISPRO PROTAMINE RECOMBINANT; INSULIN LISPRO RECOMBINANT

Application Number

21017

Product Number

3

Dosage Form

-

Strength

75 UNITS/ML;25 UNITS/ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 20563

Drug Name

HUMALOG PEN

Product Number

2

Dosage Form

-

Strength

100 UNITS/ML

Approval Date

-

20563 / 2

Active Ingredient

INSULIN LISPRO RECOMBINANT

Application Number

20563

Product Number

2

Dosage Form

-

Strength

100 UNITS/ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 20563

Drug Name

HUMALOG TEMPO PEN

Product Number

5

Dosage Form

-

Strength

100UNITS/ML

Approval Date

-

20563 / 5

Active Ingredient

INSULIN LISPRO RECOMBINANT

Application Number

20563

Product Number

5

Dosage Form

-

Strength

100UNITS/ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 19640

Drug Name

HUMATROPE

Product Number

1

Dosage Form

-

Strength

2MG/VIAL

Approval Date

-

19640 / 1

Active Ingredient

SOMATROPIN

Application Number

19640

Product Number

1

Dosage Form

-

Strength

2MG/VIAL

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 19640

Drug Name

HUMATROPE

Product Number

4

Dosage Form

-

Strength

5MG/VIAL

Approval Date

-

19640 / 4

Active Ingredient

SOMATROPIN

Application Number

19640

Product Number

4

Dosage Form

-

Strength

5MG/VIAL

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 19640

Drug Name

HUMATROPE

Product Number

5

Dosage Form

-

Strength

6MG/VIAL

Approval Date

-

19640 / 5

Active Ingredient

SOMATROPIN

Application Number

19640

Product Number

5

Dosage Form

-

Strength

6MG/VIAL

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 19640

Drug Name

HUMATROPE

Product Number

6

Dosage Form

-

Strength

12MG/VIAL

Approval Date

-

19640 / 6

Active Ingredient

SOMATROPIN

Application Number

19640

Product Number

6

Dosage Form

-

Strength

12MG/VIAL

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 19640

Drug Name

HUMATROPE

Product Number

7

Dosage Form

-

Strength

24MG/VIAL

Approval Date

-

19640 / 7

Active Ingredient

SOMATROPIN

Application Number

19640

Product Number

7

Dosage Form

-

Strength

24MG/VIAL

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 19717

Drug Name

HUMULIN 70/30

Product Number

1

Dosage Form

-

Strength

30 UNITS/ML;70 UNITS/ML

Approval Date

-

19717 / 1

Active Ingredient

INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN

Application Number

19717

Product Number

1

Dosage Form

-

Strength

30 UNITS/ML;70 UNITS/ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 19717

Drug Name

HUMULIN 70/30 PEN

Product Number

2

Dosage Form

-

Strength

30 UNITS/ML;70 UNITS/ML

Approval Date

-

19717 / 2

Active Ingredient

INSULIN RECOMBINANT HUMAN; INSULIN SUSP ISOPHANE RECOMBINANT HUMAN

Application Number

19717

Product Number

2

Dosage Form

-

Strength

30 UNITS/ML;70 UNITS/ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 18781

Drug Name

HUMULIN N

Product Number

1

Dosage Form

-

Strength

100 UNITS/ML

Approval Date

-

18781 / 1

Active Ingredient

INSULIN SUSP ISOPHANE RECOMBINANT HUMAN

Application Number

18781

Product Number

1

Dosage Form

-

Strength

100 UNITS/ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 18780

Drug Name

HUMULIN R

Product Number

1

Dosage Form

-

Strength

100 UNITS/ML

Approval Date

-

18780 / 1

Active Ingredient

INSULIN RECOMBINANT HUMAN

Application Number

18780

Product Number

1

Dosage Form

-

Strength

100 UNITS/ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 18780

Drug Name

HUMULIN R

Product Number

4

Dosage Form

-

Strength

10000 UNITS/20ML (500 UNITS/ML)

Approval Date

-

18780 / 4

Active Ingredient

INSULIN HUMAN

Application Number

18780

Product Number

4

Dosage Form

-

Strength

10000 UNITS/20ML (500 UNITS/ML)

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 18780

Drug Name

HUMULIN R KWIKPEN

Product Number

2

Dosage Form

-

Strength

1500 UNITS/3ML (500 UNITS/ML)

Approval Date

-

18780 / 2

Active Ingredient

INSULIN HUMAN

Application Number

18780

Product Number

2

Dosage Form

-

Strength

1500 UNITS/3ML (500 UNITS/ML)

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 18780

Drug Name

HUMULIN R PEN

Product Number

5

Dosage Form

-

Strength

100 UNITS/ML

Approval Date

-

18780 / 5

Active Ingredient

INSULIN RECOMBINANT HUMAN

Application Number

18780

Product Number

5

Dosage Form

-

Strength

100 UNITS/ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 761248

Drug Name

KISUNLA

Product Number

1

Dosage Form

-

Strength

350MG/20ML(17.5MG/ML)

Approval Date

-

761248 / 1

Active Ingredient

DONANEMAB-AZBT

Application Number

761248

Product Number

1

Dosage Form

-

Strength

350MG/20ML(17.5MG/ML)

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 761038

Drug Name

LARTRUVO

Product Number

1

Dosage Form

-

Strength

500MG/50ML

Approval Date

-

761038 / 1

Active Ingredient

OLARATUMAB

Application Number

761038

Product Number

1

Dosage Form

-

Strength

500MG/50ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 761109

Drug Name

LYUMJEV

Product Number

1

Dosage Form

-

Strength

100UNITS/ML(U-100)

Approval Date

-

761109 / 1

Active Ingredient

INSULIN LISPRO-AABC

Application Number

761109

Product Number

1

Dosage Form

-

Strength

100UNITS/ML(U-100)

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 761109

Drug Name

LYUMJEV

Product Number

2

Dosage Form

-

Strength

200UNITS/ML(U-200)

Approval Date

-

761109 / 2

Active Ingredient

INSULIN LISPRO-AABC

Application Number

761109

Product Number

2

Dosage Form

-

Strength

200UNITS/ML(U-200)

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 761279

Drug Name

OMVOH

Product Number

1

Dosage Form

-

Strength

300MG/15ML

Approval Date

-

761279 / 1

Active Ingredient

MIRIKIZUMAB-MRKZ

Application Number

761279

Product Number

1

Dosage Form

-

Strength

300MG/15ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 761279

Drug Name

OMVOH

Product Number

2

Dosage Form

-

Strength

100MG/ML

Approval Date

-

761279 / 2

Active Ingredient

MIRIKIZUMAB-MRKZ

Application Number

761279

Product Number

2

Dosage Form

-

Strength

100MG/ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 125547

Drug Name

PORTRAZZA

Product Number

1

Dosage Form

-

Strength

800MG/50ML

Approval Date

-

125547 / 1

Active Ingredient

NECITUMUMAB

Application Number

125547

Product Number

1

Dosage Form

-

Strength

800MG/50ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 218160

Drug Name

RETEVMO

Product Number

5

Dosage Form

-

Strength

40MG

Approval Date

-

218160 / 5

Active Ingredient

SELPERCATINIB

Application Number

218160

Product Number

5

Dosage Form

-

Strength

40MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 218160

Drug Name

RETEVMO

Product Number

6

Dosage Form

-

Strength

80MG

Approval Date

-

218160 / 6

Active Ingredient

SELPERCATINIB

Application Number

218160

Product Number

6

Dosage Form

-

Strength

80MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 761215

Drug Name

REZVOGLAR

Product Number

1

Dosage Form

-

Strength

3ML(100UNITS/ML)

Approval Date

-

761215 / 1

Active Ingredient

INSULIN GLARGINE-AGLR

Application Number

761215

Product Number

1

Dosage Form

-

Strength

3ML(100UNITS/ML)

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 125521

Drug Name

TALTZ

Product Number

1

Dosage Form

-

Strength

80MG/ML

Approval Date

-

125521 / 1

Active Ingredient

IXEKIZUMAB

Application Number

125521

Product Number

1

Dosage Form

-

Strength

80MG/ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 125469

Drug Name

TRULICITY

Product Number

1

Dosage Form

-

Strength

0.75MG/0.5ML

Approval Date

-

125469 / 1

Active Ingredient

DULAGLUTIDE

Application Number

125469

Product Number

1

Dosage Form

-

Strength

0.75MG/0.5ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 125469

Drug Name

TRULICITY

Product Number

2

Dosage Form

-

Strength

1.5MG/0.5ML

Approval Date

-

125469 / 2

Active Ingredient

DULAGLUTIDE

Application Number

125469

Product Number

2

Dosage Form

-

Strength

1.5MG/0.5ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 125469

Drug Name

TRULICITY

Product Number

3

Dosage Form

-

Strength

3MG/0.5ML

Approval Date

-

125469 / 3

Active Ingredient

DULAGLUTIDE

Application Number

125469

Product Number

3

Dosage Form

-

Strength

3MG/0.5ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 125469

Drug Name

TRULICITY

Product Number

4

Dosage Form

-

Strength

4.5MG/0.5ML

Approval Date

-

125469 / 4

Active Ingredient

DULAGLUTIDE

Application Number

125469

Product Number

4

Dosage Form

-

Strength

4.5MG/0.5ML

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 208855

Drug Name

VERZENIO

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

-

208855 / 1

Active Ingredient

ABEMACICLIB

Application Number

208855

Product Number

1

Dosage Form

-

Strength

50MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 208855

Drug Name

VERZENIO

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

-

208855 / 2

Active Ingredient

ABEMACICLIB

Application Number

208855

Product Number

2

Dosage Form

-

Strength

100MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 208855

Drug Name

VERZENIO

Product Number

3

Dosage Form

-

Strength

150MG

Approval Date

-

208855 / 3

Active Ingredient

ABEMACICLIB

Application Number

208855

Product Number

3

Dosage Form

-

Strength

150MG

Approval Date

-

Regulatory Status

Unclassified

-
Unclassified Application: 208855

Drug Name

VERZENIO

Product Number

4

Dosage Form

-

Strength

200MG

Approval Date

-

208855 / 4

Active Ingredient

ABEMACICLIB

Application Number

208855

Product Number

4

Dosage Form

-

Strength

200MG

Approval Date

-

Regulatory Status

Unclassified

Related Databases
  • FDA Inspections
    0 View
  • EDQM CEP
    10 View
  • KDMF
    0 View
  • Japan DMF
    0 View
  • Eudra GMP
    0 View
  • NDC Database
    0 View
  • FDA Approved Drugs Database
    339 View
  • Drug Prices in Switzerland
    0 View
Drug Status Breakdown
59 total
  • Unclassified
Official Source

FDA approved drug data is based on publicly available U.S. Food and Drug Administration Orange Book information.

Visit FDA Orange Book
FDA Approved Drug Record Details Preview

Explore important FDA approved drug information available in the records above.

Drug Name

ALIMTA

Application Number

21677

Product Number

1

Active Ingredient

PEMETREXED

Dosage Form

-

Strength

500MG

FDA Approved Drug Data

Approved drug product information

Regular Updates

Data maintained from official sources

Structured Database

Searchable pharmaceutical data

Reliable Data

Organized FDA drug records

Create a New Buying Request

Fields marked with * are mandatory.

Please enter quantity.
Please select a unit.
Please select quality standard.
Please select request type.
Please provide product specifications.
Please enter additional details.
Please select shipping preference.
Notice: By submitting this buying request, the provided product details and requirements may be published publicly on our marketplace.
Login to Submit